Specialists have identified a genetic polymorphism that may be important in worsening of cognitive function and progression to Alzheimer’s disease (AD) in patients with subjective cognitive decline (SCD) or mild cognitive impairment (MCI).
News
News
Daily digests from key neurology conferences, written by on-site medical journalists.
Published: 25 maj 2020